Ad
CDTX - Cidara Therapeutics Stock Trading
About | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Not available
Quote | Cidara Therapeutics Inc. (NASDAQ:CDTX)
| Last: | $0.7235 |
|---|---|
| Change Percent: | 1.99% |
| Open: | $0.6905 |
| Close: | $0.7094 |
| High: | $0.73 |
| Low: | $0.6801 |
| Volume: | 333,338 |
| Last Trade Date Time: | 12/01/2023 03:00:00 am |
News | Cidara Therapeutics Inc. (NASDAQ:CDTX)
-
SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing seriou...
-
SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing seriou...
Message Board Posts | Cidara Therapeutics Inc. (NASDAQ:CDTX)
| Subject | By | Source | When |
|---|---|---|---|
| $CDTX Should be up bigly tomorrow. Pres and | MiamiGent | investorshub | 03/28/2023 12:32:15 AM |
| $CDTX Just added @ .95 | MiamiGent | investorshub | 03/27/2023 4:27:23 PM |
| Interesting announcement by 5AM Ventures..... they | now invest | investorshub | 03/23/2023 2:52:53 PM |
| Hello Ed. Also check out $ADRX. That one | enthalpy | investorshub | 03/23/2023 12:47:37 PM |
| still losing money but is is narrowing | ed3/6me | investorshub | 03/23/2023 12:00:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
Ad
-
SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&#...
-
SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing seriou...
-
SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing seriou...